Ingevity Corp (NGVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 135,500 | 107,400 | 88,500 | 95,900 | 84,500 |
| Receivables | 189,900 | 213,400 | 191,300 | 182,000 | 216,600 |
| Inventories | 261,000 | 302,000 | 325,500 | 308,800 | 386,700 |
| TOTAL | $636,800 | $685,800 | $669,200 | $658,600 | $734,500 |
| Non-Current Assets | |||||
| PPE Net | 671,300 | 722,200 | 726,500 | 762,200 | 800,000 |
| Investments And Advances | 168,400 | 174,400 | 173,900 | 178,300 | 179,500 |
| Intangibles | 485,500 | 472,700 | 828,700 | 863,600 | 895,700 |
| Other Non-Current Assets | 249,600 | 221,100 | 168,600 | 160,600 | 157,100 |
| TOTAL | $1,574,800 | $1,590,400 | $1,897,700 | $1,964,700 | $2,032,300 |
| Total Assets | $2,211,600 | $2,276,200 | $2,566,900 | $2,623,300 | $2,766,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 96,500 | 142,400 | 153,100 | 158,400 | 197,300 |
| Accrued Expenses | 140,700 | 91,200 | 87,100 | 92,200 | 81,000 |
| TOTAL | $360,800 | $357,800 | $351,700 | $362,900 | $305,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,397,600 | 1,401,000 | 1,408,700 | 1,382,800 | 1,469,700 |
| Other Non-Current Liabilities | 173,000 | 171,000 | 173,900 | 175,300 | 168,300 |
| TOTAL | $1,636,300 | $1,633,600 | $1,647,000 | $1,629,000 | $1,743,000 |
| Total Liabilities | $1,997,100 | $1,991,400 | $1,998,700 | $1,991,900 | $2,048,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,349 | 36,345 | 36,329 | 36,236 | 36,231 |
| Common Shares | 400 | 400 | 400 | 400 | 400 |
| Retained earnings | 555,400 | 662,600 | 946,300 | 1,002,300 | 1,119,100 |
| Other shareholders' equity | -3,000 | -37,800 | -35,700 | -26,200 | -53,400 |
| TOTAL | $214,500 | $284,800 | $568,200 | $631,400 | $718,700 |
| Total Liabilities And Equity | $2,211,600 | $2,276,200 | $2,566,900 | $2,623,300 | $2,766,800 |